The article offers information on ongoing development of clinical trials and radiobiology assays to study the molecular effects of carbon ions as well as helium, lithium and oxygen ions in cancer research. Topics discussed include use of accelerators and beam-delivery systems, use of antibodies to detect DNA-repair enzymes and a computed-tomography scan showing a tumor and ion-beam dosage.